Last reviewed · How we verify

Iron oligosaccharide

Pharmacosmos A/S · Phase 3 active Small molecule

Iron oligosaccharide delivers iron in a carbohydrate-stabilized form that is absorbed through the gastrointestinal tract to replenish iron stores and treat iron deficiency.

Iron oligosaccharide delivers iron in a carbohydrate-stabilized form that is absorbed through the gastrointestinal tract to replenish iron stores and treat iron deficiency. Used for Iron deficiency anemia, Iron supplementation in patients with chronic kidney disease.

At a glance

Generic nameIron oligosaccharide
Also known asMonoFer
SponsorPharmacosmos A/S
Drug classIron supplement / Iron replacement therapy
TargetIron (Fe2+/Fe3+) absorption pathway
ModalitySmall molecule
Therapeutic areaHematology
PhasePhase 3

Mechanism of action

Iron oligosaccharide is an oral iron formulation where iron is complexed with oligosaccharides, which stabilize the iron and facilitate its absorption in the GI tract. This approach aims to improve bioavailability and reduce gastrointestinal side effects compared to traditional iron salts. The iron is then utilized by the body for hemoglobin synthesis and other iron-dependent processes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results